MORGAN JACKSON: Open Payments
NPI 1801272638 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 50 payments from 17 companies in 2025. Trend: 2023 $1,190 · 2024 $964 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $229 |
| PFIZER INC. | 11 | $174 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Amgen Inc. | 3 | $46 |
| Abbott Laboratories | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: VRAYLAR, TRELEGY ELLIPTA, NURTEC ODT, REXULTI, MOUNJARO, DALVANCE, ELIQUIS, CAPLYTA.
Industry payments across AL — which companies pay providers there.
